US Stock Market Move | Apple Inc. (AAPL.US) rose more than 2% as the Q1 financial results are imminent. Revenue and net profits are expected to show solid growth.
On Monday, Apple (AAPL.US) rose more than 2%, to $254.67.
On Monday, Apple Inc. (AAPL.US) rose more than 2%, closing at $254.67. In terms of news, Apple Inc. will announce its first quarter earnings for the fiscal year 2026 after the US stock market closes on Thursday, January 29th. Apple Inc. is expected to achieve robust revenue, net profit, and earnings per share growth. Market expectations currently predict that Apple Inc.'s Q1 revenue will increase by 11.3% year-on-year to $138.42 billion, net profit will increase by 8.4% year-on-year to $39.38 billion, and earnings per share will increase by 11.2% year-on-year to $2.67.
For Apple Inc.'s financial report for the first quarter of fiscal year 2026, the focus will once again be on iPhone demand, especially in China. Apple Inc. faces pricing pressure and challenges from local competitors in China. Investors hope to see if recent promotions and product updates have supported holiday season sales, and if the average selling price remains stable. Although Apple Inc. no longer discloses unit sales, regional revenue trends will be closely monitored as a reference for potential demand. The iPhone remains Apple Inc.'s largest single product category and drives participation in its other products and services ecosystem.
Related Articles

New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?
New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


